Additionally, PD-L2 expression on memory B cells in patients with CLL (0.2005 ± 0.1297) was reduced compared to the control group (1.956 ± 1.706; p = 0.0044). This evidence concerns the gene PDCD1LG2 and B-cell chronic lymphocytic leukemia.